– USA, CA – Surface Pharmaceuticals, Inc., a biotechnology company focused on the development and commercialization of innovative therapeutics in eye care, today announced that Shelley Thunen has joined the Board of Directors and will also serve as Chair of the Audit Committee. She strengthens a Board which already has proven expertise in clinical development and eye care.
“We’re proud to have Shelley join us to help guide our financial path as we advance in the clinic and as a company,” said CEO, Dr. Kamran Hosseini. “Her experience will be invaluable as we seek to forge a path to advance our innovative clinical programs.”
About Shelley Thunen
Shelley Thunen has extensive experience in executive leadership for medical device companies in the ophthalmic space, including serving as Chief Financial Officer for several companies who have made significant advancements in eye care such as developing the first femtosecond laser for LASIK surgery and the only intraocular lens that can be customized after cataract surgery. Ms. Thunen will also serve as Chair of the Audit Committee to help guide the financial and reporting direction for Surface as we move forward in our clinical and business development.
“Over the course of my career, I’ve had the opportunity to work with several innovators in eye care,” said Shelley Thunen. “And to me, Surface is a standout, not only because of the potential for clinical advancement in the treatment of ocular conditions but also because of the bold vision and efficient approach to clinical and business programs.”
About Surface Pharmaceuticals
Surface Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for ocular diseases. We are striving to solve key patient needs in eye care through leveraging deep expertise, a bold approach, an eye toward efficiency, and a clear, differentiated clinical advantage. Our current drug pipeline consists of three proprietary drug candidates, all utilizing Klarity, a patented delivery vehicle. We are led by an experienced and proven management team and board of directors with over 80 years of ophthalmology related professional experience.
For more information: http://surfacepharma.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.